Treatment of chronic fatigue syndrome by dietary supplementation with ω-3 fatty acids – a good idea?

Abstract 

Minor alterations of immune, neuroendocrine, and autonomic function may be associated with the chronic fatigue syndrome. ω-3 fatty acids decrease the production of putative mediators of inflammation, including interleukin-1, and tumor necrosis factor. Since interleukin-1 and tumor necrosis factor are the principal polypeptide mediators of immunoregulation, reduced production of these cytokines by dietary supplementation with ω-3, may be a possible mechanism for the treatment of chronic fatigue syndrome.

No full text is available. To read the body of this article, please view the PDF online.

• f1 Correspondence to: Dr Babak Tamizi far, Department of Education and Research, Shahrekord University of Medical Sciences, Shahrekord, Iran. Phone: +983125890; Fax: +983813335776; E-mail: babak360@yahoo.com